XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Restructuring Expense
6 Months Ended
Jun. 30, 2020
Restructuring And Related Activities [Abstract]  
Restructuring Expense

Note 7. Restructuring Expense

On June 11, 2020, following the announcement regarding the topline results from the phase 2a clinical trial of OP0201, in June 2020, Novus announced that its board of directors approved a plan to reduce the size of its workforce. The workforce reduction, which was completed in June 2020, was designed to reduce the Company’s operating expenses while it is conducting a review of development and strategic alternatives. For the three months ended June 30, 2020, Novus incurred $0.5 million in expenses related to the workforce reduction and expects to pay these amounts in the next nine months.

Total liability for restructuring expenses and their utilization are summarized as follows (in thousands):

 

 

 

For the Three Months

Ended June 30,

 

 

For the Six Months

Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Restructuring charges at beginning of period

 

$

 

 

$

 

 

$

 

 

$

 

Charged

 

 

490

 

 

 

 

 

 

490

 

 

 

 

Paid

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring charges at end of period

 

$

490

 

 

$

 

 

$

490

 

 

$